News Articles for "Drugmaker"
-
News Summary: Actavis plans Warner Chilcott deal
THE OFFER: Actavis Inc. said Monday that it has agreed to buy fellow drugmaker Warner Chilcott PLC in an all-stock deal valued at about $8.5 billion. THE P...
read more -
Lawsuit alleges Merck discriminates against women
A Merck & Co. sales representative is suing the drugmaker for at least $100 million, saying Merck doesn't give women equal opportunities for advancement a...
read more -
LinkedIn, Teradata, MSG are big movers
Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE LinkedIn Corp., down $26.08 at $...
read more -
Fitch affirms Merck ratings but downgrades outlook
Fitch Ratings said Friday it's affirmed its ratings for Merck & Co., but downgraded its rating outlook for the world's third-biggest drugmaker to "Negativ...
read more
